Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Top Cited Papers
Open Access
- 16 February 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (7), 889-896
- https://doi.org/10.1001/jama.283.7.889
Abstract
Diabetes mellitus is a leading cause of blindness in the United States.1 Randomized trials have clearly demonstrated that the risk of developing severe visual loss from proliferative diabetic retinopathy (PDR) and macular edema can be significantly reduced through the use of laser photocoagulation.2-5 Thus, screening, detection, and appropriate treatment of PDR and macular edema have the potential to significantly reduce the incidence of visual loss in patients with diabetes.Keywords
This publication has 38 references indexed in Scilit:
- Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologiesChoice Reviews Online, 1995
- Physician and Patient Prevention Practices in NIDDM in a Large Urban Managed-Care OrganizationDiabetes Care, 1995
- Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reformDiabetes Care, 1994
- Assessment of Diabetes Care by Medical Record Review: The Indian Health Service ModelDiabetes Care, 1994
- Racial Differences in the Relationship Between Blood Pressure and Risk of Retinopathy Among Individuals With NIDDMDiabetes Care, 1993
- Cost-Effectiveness of Strategies for Detecting Diabetic RetinopathyMedical Care, 1991
- Role of Diabetologist in Evaluating Diabetic RetinopathyDiabetes Care, 1991
- Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical settingBMJ, 1988
- New Management Concepts for Timely Diagnosis of Diabetic Retinopathy Treatable by PhotocoagulationDiabetes Care, 1987
- Mortality from cardiovascular diseases among diabeticsDiabetologia, 1977